BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24288498)

  • 21. Efficient delivery of small interfering RNA into cancer cells using dodecylated dendrimers.
    Chang H; Zhang Y; Li L; Cheng Y
    J Mater Chem B; 2015 Nov; 3(41):8197-8202. PubMed ID: 32262877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships of fluorinated dendrimers in DNA and siRNA delivery.
    Wang M; Cheng Y
    Acta Biomater; 2016 Dec; 46():204-210. PubMed ID: 27662807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAMAM-cRGD mediating efficient siRNA delivery to spermatogonial stem cells.
    Li T; Chen Q; Zheng Y; Zhang P; Chen X; Lu J; Lv Y; Sun S; Zeng W
    Stem Cell Res Ther; 2019 Dec; 10(1):399. PubMed ID: 31852526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycine-terminated dendritic amphiphiles for nonviral gene delivery.
    Malhotra S; Bauer H; Tschiche A; Staedtler AM; Mohr A; Calderón M; Parmar VS; Hoeke L; Sharbati S; Einspanier R; Haag R
    Biomacromolecules; 2012 Oct; 13(10):3087-98. PubMed ID: 22877231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Amino-Functional Polyester Dendrimers Based on Bis-MPA as Nonviral Vectors for siRNA Delivery.
    Stenström P; Manzanares D; Zhang Y; Ceña V; Malkoch M
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
    Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
    FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.
    Tang Y; Li YB; Wang B; Lin RY; van Dongen M; Zurcher DM; Gu XY; Banaszak Holl MM; Liu G; Qi R
    Mol Pharm; 2012 Jun; 9(6):1812-21. PubMed ID: 22548294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector.
    Tekade RK; Maheshwari RG; Sharma PA; Tekade M; Chauhan AS
    Curr Pharm Des; 2015; 21(31):4614-36. PubMed ID: 26486147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of nanocarriers for the delivery of small interfering RNA.
    Kesharwani P; Gajbhiye V; Jain NK
    Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer.
    Liu X; Liu C; Laurini E; Posocco P; Pricl S; Qu F; Rocchi P; Peng L
    Mol Pharm; 2012 Mar; 9(3):470-81. PubMed ID: 22208617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
    Hong CA; Nam YS
    Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo.
    Yu T; Liu X; Bolcato-Bellemin AL; Wang Y; Liu C; Erbacher P; Qu F; Rocchi P; Behr JP; Peng L
    Angew Chem Int Ed Engl; 2012 Aug; 51(34):8478-84. PubMed ID: 22829421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution from Covalent to Self-Assembled PAMAM-Based Dendrimers as Nanovectors for siRNA Delivery in Cancer by Coupled In Silico-Experimental Studies. Part I: Covalent siRNA Nanocarriers.
    Marson D; Laurini E; Aulic S; Fermeglia M; Pricl S
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31323863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity.
    Merkel OM; Mintzer MA; Librizzi D; Samsonova O; Dicke T; Sproat B; Garn H; Barth PJ; Simanek EE; Kissel T
    Mol Pharm; 2010 Aug; 7(4):969-83. PubMed ID: 20524664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleic acid delivery: the missing pieces of the puzzle?
    Nguyen J; Szoka FC
    Acc Chem Res; 2012 Jul; 45(7):1153-62. PubMed ID: 22428908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly Efficient and Safe Delivery of VEGF siRNA by Bioreducible Fluorinated Peptide Dendrimers for Cancer Therapy.
    Cai X; Zhu H; Zhang Y; Gu Z
    ACS Appl Mater Interfaces; 2017 Mar; 9(11):9402-9415. PubMed ID: 28228013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphiphilic Dendrimer Vectors for RNA Delivery: State-of-the-Art and Future Perspective.
    Chen J; Zhu D; Liu X; Peng L
    Acc Mater Res; 2022 May; 3(5):484-497. PubMed ID: 35782755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.
    Weber N; Ortega P; Clemente MI; Shcharbin D; Bryszewska M; de la Mata FJ; Gómez R; Muñoz-Fernández MA
    J Control Release; 2008 Nov; 132(1):55-64. PubMed ID: 18727943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clustering Small Dendrimers into Nanoaggregates for Efficient DNA and siRNA Delivery with Minimal Toxicity.
    Liu C; Shao N; Wang Y; Cheng Y
    Adv Healthc Mater; 2016 Mar; 5(5):584-92. PubMed ID: 26789529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering RNA for targeted siRNA delivery and medical application.
    Guo P; Coban O; Snead NM; Trebley J; Hoeprich S; Guo S; Shu Y
    Adv Drug Deliv Rev; 2010 Apr; 62(6):650-66. PubMed ID: 20230868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.